Zoekresultaten - 16 results
Development and implementation of novel liquid biopsy NGS panels via the OncNGS precommercial procurement (PCP) initiative
transforming oncology, but challenges such as insufficient analytical sensitivity, difficult variant interpretation, suboptimal turnaround time, limited deployment flexibility, and high costs hinder its broader ...
Recovering radiotherapy services in England: Our plan for action
visibility in the public debate as chemotherapy and other cancer treatments. This briefing explores the main drivers of lengthening waiting times for radiotherapy and what action we need at a national and ...
Delayed treatment in breast cancer patients during the COVID-19 pandemic: a population health information research infrastructure (PHIRI) case study
studied by assessing changes in the trend of the time to first treatment for women 18 or older who were diagnosed and treated for breast cancer between 2017 and 2021. Methods An observational retrospective ...
Evaluating the health and health economic impact of the COVID-19 pandemic on delayed cancer care in Belgium: A Markov model study protocol
from a health and an economic perspective. To improve cancer patient outcomes and lower society expenses, early diagnosis and timely treatment are essential. The recent COVID-19 crisis has disrupted the ...
Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework.
Cervical Dysplasia Uterine Cervical Neoplasms Abstract: AIM: The Papilloplex high-risk human papillomavirus (hrHPV) test (Genefirst, Oxford, UK) is a single tube real-time HPV test which provides multiplex ...
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.
Infections Real-Time Polymerase Chain Reaction Reproducibility of Results Sensitivity and Specificity Uterine Cervical Dysplasia Uterine Cervical Neoplasms Abstract: Human papillomavirus (HPV) assays used in ...
Assessing factors associated with long-term work disability after cancer in Belgium: a population-based cohort study using competing risks analysis with a 7-year follow-up
entering the work disability system for 11 cancer sites using the Fine and Gray model allowing for competing risks. RESULTS The overall median time of work disability was 1.59 years (95% CI 1.52 to 1.66), ...
Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening program.
than the national rate (57%), and the overall cancer incidence of 5.5/100 000 is below the national French level. The EVE database will be useful to assess trends in cervical morbidity over time and to ...
Barriers to and facilitators of compliance with clinic-based cervical cancer screening: population-based cohort study of women aged 23-60 years.
Surveys and Questionnaires Sweden Uterine Cervical Neoplasms Abstract: OBJECTIVE: This study aims to identify possible barriers to and facilitators of cervical cancer screening by (a) estimating time and ...
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
fulfil the 2009 guidelines are the following: Cervista HPV HR Test, GP5 +/6+ PCR- LMNX, an in-house E6 / E7 RT quantitative PCR and MALDI- TOF (matrix assisted laser desorptionionization time ...